Skip to main content
Skip to main content
SY logo

So-Young International Inc. (SY) Stock Analysis

$1.92 +$0.07 (+3.78%) |CouncilSplit View · 48 · C
Bottom line: Split View — our Council read (48/100) and AI Score (49/100) broadly agree. Strongest signal: Ray Dalio bullish · Biggest watch-out: Seth Klarman bearish.
MCap: $252M| Vol: 196.4K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

So-Young International Inc. (SY) trades at $1.92 with AI Score 49/100 (Grade C). So-Young International Inc. is a leading online platform in China for medical aesthetics and consumption healthcare services, connecting users with treatment providers. Market cap: $252M, Sector: Healthcare.

Price as of Jul 23, 2026 · Last analyzed: Jun 14, 2026
So-Young International Inc. is a leading online platform in China for medical aesthetics and consumption healthcare services, connecting users with treatment providers. Founded in 2013, the company focuses on discretionary medical treatments, facilitating reservations and sharing experiences in the healthcare sector.

Analyst Coverage for SY: SY does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SY against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the SY film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Split View 48/100 · C

SY: the 3 scored disciplines are evenly split. Dominant signal: Ray Dalio bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Neutral
Jim Simons
Neutral
Izzy Englander
Bearish
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Undervalued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

So-Young International Inc. (SY) Healthcare & Pipeline Overview

CEOXing Jin
Employees1,800
HeadquartersBeijing, CN
IPO Year2019

So-Young International Inc. operates a comprehensive online platform for medical aesthetics and healthcare services, enabling users to discover, review, and reserve treatments while connecting with a vast network of service providers in China and beyond.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: Jun 14, 2026

What Is the Investment Thesis for SY?

As of Jun 14, 2026 — figures reflect the data available on that date.

So-Young International Inc. presents a unique investment thesis driven by its strong market position in the rapidly growing medical aesthetics sector. With a market cap of $252M, the company operates in a lucrative industry projected to expand significantly in the coming years. The company's gross margin stands at 46.0%, indicating efficient operations and strong pricing power. Key growth catalysts include the increasing demand for discretionary medical treatments in China, the expansion of its service offerings, and the growing number of healthcare providers on its platform. However, the company faces risks such as regulatory challenges and market competition, which could impact its profit margin, currently at -15.5%. Investors should closely monitor these dynamics as they assess the company's potential for future growth.

Based on FMP financials and quantitative analysis

SY Key Highlights

  • Market cap of $252M reflects the company's position in the medical aesthetics sector.
  • Gross margin of 46.0% indicates strong operational efficiency.
  • Profit margin of -15.5% highlights current challenges in profitability.
  • The platform connects approximately 8,400 medical aesthetic providers with users.
  • The company employs around 1,800 staff to support its operations.

Who Are SY's Competitors?

SY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
CLOV Clover Health Investments, Corp. $4.55 -2.57% $2.36B 36
HCA HCA Healthcare, Inc. $371.87 -0.33% $82.5B 87
AMGN Amgen Inc. $369.39 +0.91% $200B 84
DLHTF Dialogue Health Technologies Inc. $3.79 +0.59% $255M 56
SMFR Sema4 Holdings Corp. $0.31 +26.78% $246M 60
SPOK Spok Holdings, Inc. $10.46 -1.74% $219M 83
VHIBF Vitalhub Corp. $4.63 -2.53% $293M 63
SUSRF Surgical Science Sweden AB (publ) $4.00 +0.00% $204M 55

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SY's Key Strengths?

  • Established platform with a significant user base.
  • Diverse range of services catering to various healthcare needs.
  • Strong gross margin indicating operational efficiency.

What Are SY's Weaknesses?

  • Negative profit margin indicating current financial challenges.
  • Heavy reliance on the Chinese market for revenue.
  • Limited brand recognition outside of China.

What Could Drive SY Stock Higher?

  • Expansion of service offerings into new healthcare segments.
  • Strong user engagement and content generation on the platform.
  • Potential partnerships with international healthcare providers.
  • Growth in the number of medical aesthetic service providers on the platform.
  • Introduction of telehealth services to enhance user experience.

What Are the Key Risks for SY?

  • Financial-distress signal — its Altman Z-Score of 0.86 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-15.9%) — the business is not currently generating profit on shareholder capital.
  • Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
  • Regulatory changes impacting the medical aesthetics industry.
  • Intense competition from other healthcare platforms.
  • Economic downturns affecting consumer spending on discretionary treatments.
  • Fluctuations in currency exchange rates impacting ADR value.

What Are the Growth Opportunities for SY?

  • Expansion of Service Offerings: So-Young International Inc. has the opportunity to broaden its range of services beyond medical aesthetics into other healthcare segments, such as wellness and preventive care. This expansion could tap into a larger market, estimated to reach $100 billion in China by 2025, allowing the company to diversify its revenue streams and attract a broader customer base.
  • Increased Digital Engagement: With the rise of digital health solutions, So-Young can enhance its platform to include telehealth services, which are projected to grow at a CAGR of 25% over the next five years. By integrating virtual consultations and follow-up services, the company can improve user engagement and satisfaction, driving higher reservation rates.
  • Strategic Partnerships: Collaborating with leading healthcare providers and technology firms can enhance So-Young's service offerings and market reach. Partnerships could facilitate access to advanced medical technologies and innovative treatment options, positioning the company as a leader in the healthcare information services sector and potentially increasing its market share.
  • International Market Penetration: So-Young has the potential to expand its platform internationally, targeting markets with growing demand for medical aesthetics. The global medical aesthetics market is expected to reach $25 billion by 2027, providing a significant opportunity for revenue growth through international service provider partnerships and localized marketing strategies.
  • Enhanced User Experience through AI: Leveraging artificial intelligence to personalize user experiences on the platform can significantly improve customer satisfaction. By analyzing user preferences and treatment histories, So-Young can offer tailored recommendations, which may lead to increased conversion rates and higher customer retention.

What Opportunities Does SY Have?

  • Expanding into international markets with growing demand.
  • Integrating telehealth services to enhance user experience.
  • Forming strategic partnerships to broaden service offerings.

What Threats Does SY Face?

  • Intense competition from other healthcare platforms.
  • Regulatory changes affecting the medical aesthetics industry.
  • Economic downturns impacting discretionary spending on healthcare.

What Are SY's Competitive Advantages?

  • Strong brand recognition in the medical aesthetics sector.
  • Large network of service providers enhances user choice.
  • Comprehensive platform that integrates content, reservations, and reviews.
  • Established user base with high engagement rates.
  • Expertise in the healthcare information services industry.

What Does SY Do?

Founded in 2013 and headquartered in Beijing, So-Young International Inc. has established itself as a prominent online platform in the medical aesthetics and consumption healthcare sector. The company primarily focuses on discretionary medical treatments, catering to a growing demand in the People's Republic of China and internationally. So-Young's platform allows users to explore content related to medical aesthetics, share personal experiences, and reserve treatment services from a network of over 8,400 medical aesthetic service providers and 5,000 healthcare service providers as of December 31, 2021. The platform not only facilitates reservations but also provides valuable insights into treatment trends, user ratings, and reviews through its Beauty Diaries blog. Additionally, So-Young offers a range of services including Software as a Service, consulting, and training programs for medical service providers, along with internet information and technology advisory services. The company also engages in the sale of medical equipment and microfinance services, further diversifying its revenue streams. As a leader in its field, So-Young International Inc. is well-positioned to capitalize on the increasing consumer interest in medical aesthetics and healthcare services.

What Products and Services Does SY Offer?

  • Operates an online platform for medical aesthetics and healthcare services.
  • Facilitates reservations for various medical treatments.
  • Provides content and user experiences related to medical aesthetics.
  • Offers Software as a Service for healthcare providers.
  • Conducts training and consulting services for medical service providers.
  • Sells medical equipment and offers microfinance services.

How Does SY Make Money?

  • Generates revenue through service reservations made on its platform.
  • Offers subscription-based Software as a Service for healthcare providers.
  • Provides consulting and training services for medical aesthetics professionals.
  • Sells medical equipment and related services.
  • Engages in microfinance services to support healthcare providers.

What Industry Does SY Operate In?

The medical aesthetics and healthcare information services industry is experiencing robust growth, driven by increasing consumer demand for cosmetic procedures and healthcare services. The market is characterized by a shift towards digital platforms that facilitate service reservations and enhance consumer experiences. So-Young International Inc. operates in a competitive landscape, where it differentiates itself through its comprehensive platform that not only connects users with service providers but also offers valuable content and insights. As the industry continues to evolve, companies that can effectively leverage technology and consumer engagement are well-positioned for success.

Who Are SY's Key Customers?

  • Individuals seeking medical aesthetic treatments.
  • Medical aesthetic service providers looking to attract customers.
  • Healthcare professionals seeking training and consulting services.
  • Companies in need of medical equipment and technology solutions.
  • Consumers interested in health and wellness services.
AI Confidence: 65% Updated: Jun 14, 2026

So-Young International Inc. (SY) Valuation Context

Valued at $252M, SY is classified as a micro-cap stock. Relative to its peer group, SY's quantitative score of 49/100 is below the peer average of 65/100.

ROE -16%Key Financial Metrics

Return on equity for So-Young International Inc. stands at -15.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -9.7%, showing how much profit it generates from its asset base. Its free cash flow yield is -19.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.73 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -16.9%, the inverse of the P/E and a quick read on earnings relative to price.

F-Score 3/9Financial Health

So-Young International Inc.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 0.86 places it in the distress zone, a signal of elevated financial risk.

FY2026 estForward Outlook

Wall Street analysts project So-Young International Inc. revenue of about $2.05B for fiscal 2026, with EPS near $-1.67.

SY Financials

Fundamental Snapshot

Revenue Growth (FY)
+1.0%
Net Income Growth (FY)
+60.0%
EPS Growth (FY)
+59.6%
Free Cash Flow Growth (FY)
-242.5%
Return on Equity (TTM)
-15.9%
Current Ratio
1.7

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • So-Young's focus on medical aesthetics in China positions them well in a growing market. Think of it like Lululemon riding the athleisure wave, but for beauty.
  • Recent insider activity suggests confidence in the company's future. It's like executives buying their own stock after a dip - they see value.
  • The community sentiment seems to be improving, indicating a shift in market perception. It's similar to how Tesla's stock turned around in 2020 after positive sentiment grew.
  • There's a growing perception that the company is undervalued, creating potential for upward movement. This mirrors situations where value investors see potential where others don't.

Bear Case

  • Regulatory risks in the Chinese market remain a significant concern. It's like navigating the changing rules after the 2008 financial crisis.
  • Community sentiment, while improving, still shows signs of skepticism regarding the company's long-term growth. This is similar to the doubts surrounding some tech companies after the dot-com bubble burst.
  • Increased competition in the medical aesthetics sector could erode So-Young's market share. It's like established players facing new disruptors in any industry.
  • Market perception is that the company's growth is slowing, leading to concerns about future profitability. This is akin to companies struggling to maintain momentum after initial success.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · February 2026

SY Latest News

SY Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for SY.

Price Targets

Wall Street price target analysis for SY.

SY MoonshotScore

49/100

What does this score mean?

The MoonshotScore rates SY 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Xing Jin

CEO

Xing Jin has extensive experience in the healthcare technology sector, having led So-Young International Inc. since its inception in 2013. With a strong background in business management and technology, he has been instrumental in the company's growth and innovation. Prior to founding So-Young, he held various leadership roles in technology and healthcare companies, contributing to his expertise in the field.

Track Record: Under Xing Jin's leadership, So-Young has grown its user base significantly and expanded its service offerings. He has successfully navigated the company through challenges in the competitive healthcare landscape, focusing on operational efficiency and user engagement.

So-Young International Inc. ADR Information Sponsored

An American Depositary Receipt (ADR) is a negotiable certificate issued by a U.S. bank representing a specific number of shares in a foreign company's stock. So-Young International Inc. operates as a Level II ADR, allowing U.S. investors to trade shares of the company on U.S. exchanges while maintaining its primary listing in China.

  • Home Market Ticker: The primary stock exchange for So-Young International Inc. is in Beijing, China.
  • ADR Level: 2
  • ADR Ratio: 1:1
Currency Risk: Investors in So-Young's ADR face currency risk as fluctuations in the exchange rate between the U.S. dollar and the Chinese yuan can affect the value of their investments. Changes in currency values can impact the returns on investment when converting profits back to U.S. dollars.
Tax Implications: As an ADR, So-Young's dividends, if any, would be subject to a foreign withholding tax rate, which can vary based on tax treaties between the U.S. and China. Investors should consult tax professionals regarding specific implications.
Trading Hours: The trading hours for the primary market in China differ from U.S. trading hours, which may affect liquidity and trading strategies for investors holding So-Young's ADRs.

Common Questions About SY (Healthcare)

What does the AI Score mean for SY?

SY holds an AI Score of 49/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. So-Young International Inc. is a leading online platform in China for medical aesthetics and consumption healthcare services, connecting users with treatment providers. Founded in 2013, the company …

What does So-Young International Inc. do?

So-Young International Inc. operates an online platform that connects users with medical aesthetic and healthcare service providers. The platform facilitates reservations for various treatments, provides valuable content and user experiences, and offers services such as Software as a Service and consulting for healthcare professionals.

What are the main risks for SY?

So-Young International Inc. faces several risks, including regulatory changes that could impact the medical aesthetics industry, intense competition from other healthcare platforms, and economic downturns that may reduce consumer spending on discretionary healthcare treatments. Additionally, fluctuations in currency exchange rates can affect the value of its ADR.

What revenue streams does So-Young International Inc. have in healthcare?

So-Young generates revenue through various streams, including service reservations made on its platform, subscription fees for its Software as a Service offerings, consulting and training services for healthcare providers, sales of medical equipment, and microfinance services to support healthcare providers.

What are the key factors to evaluate for SY?

So-Young International Inc. (SY) holds an AI score of 49/100 (low). Not financial advice.

How frequently does SY data refresh on this page?

SY's price was last updated on Jul 23, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven SY's recent stock price performance?

So-Young International Inc. (SY) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established platform with a significant user base. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider SY overvalued or undervalued right now?

So-Young International Inc. (SY) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research SY before investing?

Before investing in So-Young International Inc. (SY), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Data Sources

Popular Stocks